Seropositivity/seroprotection rates and GMTs/GMCs before and 1 month after primary vaccination (ATP cohort for the primary immunogenicity study)

*DTPw-HBV/Hib-MenAC
**DTPw-HBV/Hib
PSC/A = serogroup S/A polysaccharide ; PRP = polyribosylribitol phosphate; BPT = Bortedella pertussis ; HBs = Hepatitis B surface antigen
Dilution titre (SBA), μg/ml (anti PSA/C, anti PRP), IU/ml (anti–tetanus and anti-diphtheria), EL U/ml (anti-BP), mIU/ml (anti-HBs).
(1): anti PRP ≥ 0.15 μg/ml ;
(2): anti PRP ≥ 1.0 μg/ml
†≥0.1IU/ml by ELISA or ≥ 0.016IU/ml by VERO cell neutralisation test when concentration by ELISA<0.1IU/ml (seroprotection);
††: by ELISA
N = number of subjects with available results; Pre = pre-primary vaccination; Post-dose = 1 month post-dose 3
95% CI = 95% confidence interval
GMT/GMC = geometric mean antibody titre/concentration calculated on all subjects